Every single machine learning (ML)-driven breakthrough, from language translation to Go championships, was immediately preceded not by an algorithmic innovation but by a massive, well-controlled, purpose-built dataset. An ML-driven breakthrough in medicinal chemistry is going to require a similar dataset, but such high-quality, well-structured experimental data doesn’t exist yet. We're building that data set by making physical measurements of lots of targets (with automated in-house protein production) screened against lots of compounds (with DNA-encoded chemical libraries). We're also building the ML models, that will eventually be generalizable across any protein and novel medicines using insights from our models.
| Website | http://leash.bio |
| Employees | 12 (9 on RocketReach) |
| Founded | 2021 |
| Industry | Biotechnology Research |
| Keywords | Machine Learning Datasets, Synthetic Data Generation, Data Annotation, Ai Data Solutions, High Quality Datasets, Training Datasets, Custom Datasets, Data Augmentation, Ai Data Services, Machine Learning Data, Artificial Intelligence Data, Dataset Creation, Data Science Tools, Data Engineering, Deep Learning Datasets |
| Competitors | General Petroleum Inc., DNA My Dog, Alphapet.Com, VETGENOMICS SL, Canadian Animal Network Ltd, Avian Research Assoc, petwise (view competitors) |
Looking for a particular Leash Bio employee's phone or email?
Ian Quigley is the Co-Founder, CEO of Leash Bio.
9 people are employed at Leash Bio.
Leash Bio is based in Salt Lake City, Utah.